135 related articles for article (PubMed ID: 2109999)
21. Second malignancies following pure seminoma.
Rüther U; Dieckmann KP; Bussar-Maatz R; Eisenberger F
Oncology; 2000; 58(1):75-82. PubMed ID: 10644944
[TBL] [Abstract][Full Text] [Related]
22. Treatment and outcome of patients with extragonadal germ cell tumours--the Norwegian Radium Hospital's experience 1979-94.
Dueland S; Stenwig AE; Heilo A; Høie J; Ous S; Fosså SD
Br J Cancer; 1998; 77(2):329-35. PubMed ID: 9461006
[TBL] [Abstract][Full Text] [Related]
23. Secondary neoplasms following treatment of malignant germ cell tumors.
Bokemeyer C; Schmoll HJ
J Clin Oncol; 1993 Sep; 11(9):1703-9. PubMed ID: 8394879
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group.
Fosså SD; Droz JP; Stoter G; Kaye SB; Vermeylen K; Sylvester R
Br J Cancer; 1995 Mar; 71(3):619-24. PubMed ID: 7880748
[TBL] [Abstract][Full Text] [Related]
25. Secondary malignant neoplasms in testicular cancer survivors.
Curreri SA; Fung C; Beard CJ
Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
[TBL] [Abstract][Full Text] [Related]
26. Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.
Swerdlow AJ; Higgins CD; Smith P; Cunningham D; Hancock BW; Horwich A; Hoskin PJ; Lister TA; Radford JA; Rohatiner AZ; Linch DC
J Clin Oncol; 2011 Nov; 29(31):4096-104. PubMed ID: 21969511
[TBL] [Abstract][Full Text] [Related]
27. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.
Swerdlow AJ; Barber JA; Horwich A; Cunningham D; Milan S; Omar RZ
Br J Cancer; 1997; 75(1):116-23. PubMed ID: 9000608
[TBL] [Abstract][Full Text] [Related]
28. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
[TBL] [Abstract][Full Text] [Related]
29. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.
Swerdlow AJ; Barber JA; Hudson GV; Cunningham D; Gupta RK; Hancock BW; Horwich A; Lister TA; Linch DC
J Clin Oncol; 2000 Feb; 18(3):498-509. PubMed ID: 10653865
[TBL] [Abstract][Full Text] [Related]
30. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
[TBL] [Abstract][Full Text] [Related]
32. Medical treatment of advanced testicular cancer.
Feldman DR; Bosl GJ; Sheinfeld J; Motzer RJ
JAMA; 2008 Feb; 299(6):672-84. PubMed ID: 18270356
[TBL] [Abstract][Full Text] [Related]
33. Second primary cancer in irradiated stage I testicular seminoma.
Stein ME; Steiner M; Lachter J; Kessel I; Moskovitz B; Kuten A
Strahlenther Onkol; 1993 Nov; 169(11):672-7. PubMed ID: 8248844
[TBL] [Abstract][Full Text] [Related]
34. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
35. Multiple primary neoplasms in patients with testicular germ cell tumor.
Dieckmann KP; Wegner HE; Krain J
Oncology; 1994; 51(5):450-8. PubMed ID: 8052488
[TBL] [Abstract][Full Text] [Related]
36. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy.
Kawaguchi T; Matsumura A; Iuchi K; Ishikawa S; Maeda H; Fukai S; Komatsu H; Kawahara M
Jpn J Clin Oncol; 2006 Jan; 36(1):7-11. PubMed ID: 16368713
[TBL] [Abstract][Full Text] [Related]
37. Fertility after testicular cancer treatments: results of a large multicenter study.
Huyghe E; Matsuda T; Daudin M; Chevreau C; Bachaud JM; Plante P; Bujan L; Thonneau P
Cancer; 2004 Feb; 100(4):732-7. PubMed ID: 14770428
[TBL] [Abstract][Full Text] [Related]
38. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.
Travis LB; Gospodarowicz M; Curtis RE; Clarke EA; Andersson M; Glimelius B; Joensuu T; Lynch CF; van Leeuwen FE; Holowaty E; Storm H; Glimelius I; Pukkala E; Stovall M; Fraumeni JF; Boice JD; Gilbert E
J Natl Cancer Inst; 2002 Feb; 94(3):182-92. PubMed ID: 11830608
[TBL] [Abstract][Full Text] [Related]
40. Secondary acute monocytic leukemia occurring during the treatment of a testicular germ cell tumor. A case report and review of the literature.
Nonomura N; Murosaki N; Kojima Y; Kondoh N; Seguchi T; Takeda Y; Oji Y; Ogawa H; Sugiyama H; Miki T; Okuyama A
Urol Int; 1997; 58(4):239-42. PubMed ID: 9253126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
